Dr. Josep Dalmau offered an In-House Seminar on autoimmune encephalitis
Dr. Josep Dalmau leads the IDIBAPS group Pathogenesis of autoimmune neuronal disorders, where he studies a group of disorders at the intersection o...
Dr. Josep Dalmau leads the IDIBAPS group Pathogenesis of autoimmune neuronal disorders, where he studies a group of disorders at the intersection o...
The TV3 Telethon Foundation held this evening a ceremony at the Barcelona Biomedical Research Park, where they presented the projects selected to b...
For the first time, scientists have used new technology which analyses the whole genome to find the cause of a genetic disease in what has previous...
The International Society for Bipolar Disorders (ISBD) recently presented an international consensus on the use of antidepressants in bipolar disor...
Casal Infantil Urgell, a space for children's entertainment within the Centre Cívic Urgell in the Eixample district, organizes a family and solidar...
ZEB proteins have recently acquired great relevance in molecular oncology because of their ability to regulate invasive and metastatic carcinomas t...
The Myelin Repair Foundation and Bionure have entered a collaborative partnership agreement to advance therapeutics development for Multiple Sclero...
The Catalan biotech company AB-Biotics has acquired the rights to a patent of a technology developed by Universitat de Barcelona (UB), IDIBAPS, Ho...
Mantle cell lymphoma is a very aggressive and difficult to treat cancer originated in blood cells and lymph nodes. To identify the molecular altera...
The Journal of Hepatology is the official journal of the European Association for the Study of the Liver (EASL), and a key resource in the specialt...